Home › Esophageal Adenocarcinoma › Virginia › Arlington
Esophageal Adenocarcinoma clinical trials in Arlington, VA
11 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RecruitingPhase 3
- Inova Fairfax Hospital, Falls Church · 4 mi away
- Inova Schar Cancer Institute, Fairfax · 11 mi away
- Inova Fair Oaks Hospital, Fairfax · 11 mi away
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RecruitingPhase 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mi away
- Virginia Cancer Specialists, PC, Fairfax · 11 mi away
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
RecruitingPhase 2/3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · 11 mi away
- Virginia Cancer Specialists, PC, Reston · 14 mi away
- and 1 more
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi away
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, Fairfax · 11 mi away
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RecruitingPhase 1
- Normunity Investigational Site, Fairfax · 11 mi away
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecruitingPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi away
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Virginia Cancer Specialists, Fairfax · 11 mi away
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Virginia Cancer Specialists, Fairfax · 11 mi away
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Research Site, Fairfax · 11 mi away
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Virginia, Fairfax · 11 mi away
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Nashville, TN11 studies
- Durham, NC10 studies
- St. Louis, MO9 studies
- Jacksonville, FL9 studies
- Rochester, MN9 studies
- Baldwin Park, CA9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
- Philadelphia, PA8 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Breast Cancer47 studies
- Ovarian Cancer46 studies
- Lung Cancer41 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Stomach Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.